Search alternatives:
point decrease » point increase (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
Showing 941 - 960 results of 102,088 for search '(( 5 c decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.00s Refine Results
  1. 941
    Geometric mean concentrations of 5 most abundant PCDD/F congeners and the sum of other congeners (A), and PCDD and PCDF TEQ (C) in different study areas during the first (1972–1986), second (1987–2001) and third (2002–2017) trimester of the study.

    Geometric mean concentrations of 5 most abundant PCDD/F congeners and the sum of other congeners (A), and PCDD and PCDF TEQ (C) in different study areas during the first (1972–1986... by Matti Viluksela (321291)

    Published 2024
    Save to List
    Saved in:
  2. 942
    FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway.

    FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway. by Ramazan Kurt (449801)

    Published 2015
    Save to List
    Saved in:
  3. 943
    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6.

    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6. by Leda Castaño Barrios (8524317)

    Published 2021
    Save to List
    Saved in:
  4. 944
    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R.

    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R. by Patricia de Godoy Bueno (731717)

    Published 2015
    Save to List
    Saved in:
  5. 945
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  6. 946
    Fig 5 -

    Fig 5 - by Mary J. Obayemi (11813022)

    Published 2021
    Save to List
    Saved in:
  7. 947
    Fig 5 -

    Fig 5 - by Torsten Schober (20485754)

    Published 2024
    Save to List
    Saved in:
  8. 948
    Reduced ADAMTS-12 expression levels decrease EVT invasion.

    Reduced ADAMTS-12 expression levels decrease EVT invasion. by Alexander G. Beristain (225001)

    Published 2011
    Save to List
    Saved in:
  9. 949
    Higher baseline PV rates decrease the need for interneuron specialization.

    Higher baseline PV rates decrease the need for interneuron specialization. by Joram Keijser (12475353)

    Published 2022
    Save to List
    Saved in:
  10. 950
    Early increase and later decrease in GSK-3β activity.

    Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

    Published 2013
    Save to List
    Saved in:
  11. 951
    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice.

    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 952
    Decrease of actin velocity when passing confined TCR clusters.

    Decrease of actin velocity when passing confined TCR clusters. by Cheng-han Yu (244912)

    Published 2010
    Save to List
    Saved in:
  13. 953
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 954
    Fig 5 -

    Fig 5 - by Jacob C. Jentzer (4746999)

    Published 2022
    Save to List
    Saved in:
  15. 955
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 956
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 957
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 958
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 959
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 960
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: